Chlordiazepoxide Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Chlordiazepoxide Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

CHLORDIAZEPOXIDE HYDROCHLORIDE DESCRIPTION



Chlordiazepoxide Hydrochloride





CLINICAL PHARMACOLOGY



Animal Pharmacology




Effects on Reproduction


INDICATIONS & USAGE




CHLORDIAZEPOXIDE HYDROCHLORIDE CONTRAINDICATIONS



WARNINGS



Usage in Pregnancy
An increased risk of congenital malformations associated with the use of minor tranquilizers (chlordiazepoxide, diazepam and meprobamate)during the first trimester of pregnancy has been suggested in several studies. Because use of these drugs is rarely a matter of urgency, their use during this period should almost always be avoided. The possibility that a woman of childbearing potential may be pregnant at the time of institution of therapy should be considered. Patients should be advised that if they become pregnant during therapy or intend to become pregnant they should communicate with their physicians about the desirability of discontinuing the drug.

DRUG ABUSE AND DEPENDENCE

PRECAUTIONS




PEDIATRIC USE

DOSAGE AND ADMINISTRATIONPRECAUTIONS

INFORMATION FOR PATIENTS



CHLORDIAZEPOXIDE HYDROCHLORIDE ADVERSE REACTIONS





DRUG ABUSE AND DEPENDENCE




OVERDOSAGE


CONTRAINDICATIONSWARNINGSPRECAUTIONS

DOSAGE & ADMINISTRATION









HOW SUPPLIED















PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Chlordiazepoxide Hydrochloride

Chlordiazepoxide Hydrochloride

Chlordiazepoxide Hydrochloride

Chlordiazepoxide Hydrochloride CAPSULE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-477(NDC:0555-0158)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
CHLORDIAZEPOXIDE HYDROCHLORIDE CHLORDIAZEPOXIDE 5 mg

Inactive Ingredients

Ingredient Name Strength
D&C YELLOW NO. 10
FD&C BLUE NO. 1
ALUMINUM OXIDE
GELATIN
ANHYDROUS LACTOSE
cellulose, microcrystalline
SHELLAC
titanium dioxide
D&C RED NO. 33
FD&C BLUE NO. 2
FD&C RED NO. 40
propylene glycol
FERROSOFERRIC OXIDE

Product Characteristics

Color Size Imprint Code Shape
yellow 14 mm barr;158 CAPSULE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-477-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA084768 2011-08-11


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.